We serve life sciences organizations where validated systems, GxP compliance, and patient safety are not compliance checkboxes. They are operational requirements that directly affect product quality, regulatory standing, and the people who depend on the products and therapies you bring to market.
Drug manufacturers operating under 21 CFR Parts 210/211 and cGMP requirements. Quality and validation work here demands rigorous IQ/OQ/PQ documentation, audit trail integrity, and change-controlled operations across quality systems, laboratory systems, and validated ERP platforms. All are subject to FDA inspection at any time.
Biologics and biosimilar manufacturers where validated systems underpin batch record integrity, manufacturing execution, and quality event management. Biotech organizations scaling from clinical to commercial production face particularly complex quality and validation requirements as processes and regulatory oversight intensify.
Advanced therapy developers transitioning to commercial biologics manufacturing, including cell and gene therapy organizations, operating at the frontier of regulated production. These programs require quality and validation expertise calibrated to complex, patient-specific processes, evolving FDA guidance on ATMPs, and quality systems supporting the traceability demands of autologous and allogeneic therapies.
Class II and Class III device manufacturers operating under 21 CFR Part 820 (QSR) and ISO 13485. Quality and validation work here spans design controls, complaint handling, CAPA, and production process validation, across quality systems and validated ERP infrastructure. All require validated system support under FDA and EU MDR/IVDR requirements.
Contract development and manufacturing organizations face compounded complexity: maintaining multiple client quality systems within shared validated infrastructure. CDMO and CMO environments require professionals who understand multi-client GMP operations, quality agreement compliance, and the validation implications of shared systems serving diverse pharmaceutical and biotech customers.
Life sciences organizations operating across the GxP spectrum, including GMP, GLP, and GCP environments, where validated systems must support compliant data integrity, operations, and supply chain quality. These environments require professionals who understand GxP obligations and their validated system dependencies.
Large molecule biologics and vaccine manufacturers where validated production and quality systems are integral to lot release, batch record management, and regulatory submission integrity. These environments require professionals who understand process analytical technology, cold chain traceability, and sterility assurance demands unique to biologics GMP manufacturing.
Specialty pharmaceutical manufacturers, including sterile injectables, oncology products, and OTC manufacturers, where product complexity and risk profile drive stringent validation requirements. Sterile manufacturing environments require validated systems that support environmental monitoring, cleanroom controls, and aseptic production process documentation.
Pharmaceutical and biotech quality control and analytical laboratories that directly support manufacturing operations, where LIMS, chromatography data systems, and enterprise quality platforms must be validated under GLP and GMP requirements. These environments demand professionals who understand data integrity, instrument qualification, and the integration of laboratory systems with broader quality and validation infrastructure.
Every search, every candidate evaluation, and every client engagement operates within the context of GxP-regulated life sciences. We do not split this practice across industries. That concentration is what makes it possible to screen with the specificity that pharmaceutical, biotech, medical device, and CDMO organizations actually need.
Tell us about your organization, validated systems environment, and Quality & Validation need. We'll scope the engagement against your specific GxP context.